The Cancer Genome Atlas is set to finish up next year after sequencing some 10,000 samples from about 20 different cancer types. TCGA has found, ScienceInsider notes, a number of new cancer genes and confirmed others that were previously identified. But with its price tag reaching over $375 million, some critics say it has been too expensive, though many disagree.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.